Chhabra, D <br/><br/>
Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Nov 2013 
 - 2902-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.12437  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Allografts<br/>Anti-Inflammatory Agents--administration & dosage<br/>Calcineurin Inhibitors<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Graft Rejection--diagnosis<br/>Graft Survival--drug effects<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Kidney Failure, Chronic--complications<br/>Kidney Function Tests<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Postoperative Complications<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Sirolimus--therapeutic use<br/>Survival Rate<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Tacrolimus--therapeutic use